|
CYB003 Clinical Trials
3 actively recruiting trials across 3 locations
Birmingham, Alabama1 trial
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
UAB Psychiatry and Behavioral Neurology
Phase 3
Phoenix, Arizona1 trial
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Scottsdale Research Institute
Phase 3
San Francisco, California1 trial
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Open Mind Collective / UCSF Medical Center - Mount Zion
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.